Abstract. Baicalein has efficient antitumor properties and has been reported to promote the apoptosis of several human cancer cell lines. Decidual protein induced by progesterone (DEPP), a transcriptional target of Forkhead Box O, was originally identified from the human endometrial stromal cell cDNA library. However, the expression and physiological functions of DEPP in human colon cancer cells remain to be fully elucidated. In the present study, it was reported that baicalein stimulated apoptosis and morphological changes of HCT116, A549 and Panc-1 cells in a dose-dependent manner. It also upregulated the mRNA and protein levels of DEPP and growth arrest and DNA damageinducible 45α (Gadd45a). In addition, the overexpression of DEPP promoted mitogen-activated protein kinase (MAPK) phosphorylation. To further investigate the role of DEPP and Gadd45a in baicalein-induced apoptosis, HCT116 cells were transfected with small interfering RNA against either DEPP or Gadd45a as in vitro models. Through an Annexin V/PI double staining assay, it was observed that baicalein-induced apoptosis was impaired by the inactivation of either DEPP or Gadd45a, which in turn restricted the baicalein-induced activation of caspase-3 and caspase-9 and phosphorylation of MAPKs. In addition, the inhibition of c-Jun N-terminal kinase (JNK)/p38 activity with SP600125/SB203580 decreased the expression of Gadd45a, whereas the inactivation of extracellular signal-regulated kinase with SCH772984 had no effect on the expression of Gadd45a. Taken together, these results demonstrated that baicalein induced the upregulation of DEPP and Gadd45a, which promoted the activation of MAPKs with a positive feedback loop between Gadd45a and JNK/p38, resulting in a marked apoptotic response in human colon cancer cells. These results indicated that baicalein is a potential antitumor drug for the treatment of colon cancer.
Introduction
Natural products isolated from plants have attracted increased interest due to their potent biological and pharmaceutical activities (1) . Baicalein (5,6,7-trihydroxyflavone) extracted from the dry root of Scutellaria baicalensis Georgi, also known as Baikal skullcap, has a wide range of pharmacological functions and has been reported to possess potential antitumor activities against human liver cancer (2), breast cancer (3) (4) (5) (6) and lung cancer cells (7) . Multiple mechanisms are associated with its antitumor activity, however, the detailed mechanisms of baicalein-induced apoptosis in the HCT116 human colon cancer cell line remain to be fully elucidated.
Decidual protein induced by progesterone (DEPP) was originally identified from the human endometrial stromal cell cDNA library as a progesterone-induced gene (8) . It is expressed in multiple tissues, including the placenta, ovary, kidney, white adipose and liver (9, 10) . In our previous study, DEPP was markedly upregulated in baicalein-treated HCT116 cells as assessed by microarray. Additionally, previous reports have suggested an association between DEPP and tumor cell death (8) . However, there have been no reports on the physiological functions of DEPP in human colon cancer cells.
Therefore, it was hypothesized that DEPP may be involved in the baicalein-induced cell death of HCT116 cells.
Growth arrest and DNA damage-inducible 45α (Gadd45a) is a member of the Gadd45 family, the constituents of which can interact with pivotal cell effectors, including p21, p38, proliferating cell nuclear antigen, Cdc2/Cyclin B1 and mitogenactivated protein kinase kinase kinase 4 (11) . In addition, Gadd45a is a vital regulator of cell cycle arrest, apoptosis and differentiation, all of which are strictly regulated by p53 (12) . Gadd45a has been shown to be crucial in suppressing tumor cell growth (13, 14) . However, whether baicalein-induced apoptosis is associated with the activity of Gadd45a remains to be elucidated. Therefore, in the present study, experiments were performed to investigate whether Gadd45a and DEPP are involved in the baicalein-stimulated apoptosis of human colon cancer cells and to examine the mechanism involved in this activity.
The results of the present study verified that baicalein significantly stimulated the apoptosis of HCT116, A549 and Panc-1 cells, upregulated the expression of DEPP and Gadd45a, and triggered the phosphorylation of MAPKs. Further experiments revealed that, as DEPP increased the protein and mRNA levels of Gadd45a, the expression of DEPP and Gadd45a contributed to baicalein-induced apoptosis and MAPK activation. Inhibiting c-Jun N-terminal kinase (JNK)/p38 signaling also reduced the expression of Gadd45a, however, there was no such change in the inactivation of extracellular signal-regulated kinase (ERK). Taken together, these findings identified the essential role of DEPP and Gadd45a in baicalein-induced apoptosis and indicated that baicalein may be a promising antitumor agent for the treatment of colon cancer in humans.
Materials and methods
Cell cultures and drug treatments. The HCT116, A549, Panc-1 and FHC (normal human colorectal mucosal cells) cell lines were obtained from American Type Culture Collection (Rockville, MD, USA) and were grown in RPMI 1640 medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (CellMax, Beijing, USA) and penicillinstreptomycin (Beyotime Institute of Biotechnology, Nanjing, China). The cells were cultured in a humidified incubator at 37˚C and 5% CO 2 and were exposed to the indicated concentrations (0, 10, 20 or 40 µM) of baicalein (Jiangsu Institute for Food and Drug Control, Nanjing, China), 1 µM gemcitabine (cat. no. G8970, Beijing Solarbio Science & Technology Co., Ltd., Beijing, China), SP600125 (cat. no. S1460, Selleck Chemicals, Houston, TX, USA), SB203580 (cat. no. S1076, Selleck Chemicals) or SCH772984 (cat. no. S7101, Selleck Chemicals).
Western blot analysis. The cell lysates were prepared with RIPA buffer containing PMSF (Beyotime Institute of Biotechnology). Protein concentration was determined by Enhanced Bicinchoninic Acid Protein assay kit (cat. no. P0010, Beyotime Institute of Biotechnology). Equal quantities (50 µg) of cellular protein were loaded onto a 12% SDS-PAGE gel and then transferred onto a PVDF membrane (cat. no. IPVH00010, EMD Millipore, Billerica, MA, USA). The membranes were blocked by 5% non-fat milk in Tris-buffered saline with 0.07% Tween-20 for 2 h and incubated with specific primary antibodies (1:1,000) in 1% bovine serum albumin (Biosharp, Hefei, China) MTT proliferation assay. The cells were treated with the indicated concentrations of Baicalein at 37˚C for 48 h. Subsequently, MTT was added to reach a final concentration of 5 mg/ml for 4 h. The supernatant was removed, and the purple-colored formazan precipitate was dissolved in 150 µl DMSO and measured at 490 nm with a microplate reader (iMark; Bio-Rad Laboratories, Inc.).
Statistical analysis. All data are shown as the mean ± standard deviation of at least three independent experiments. Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA), and data were analyzed using one-way analysis of variance, followed by the Dunnett's multiple comparison test. In certain cases, Student's t-test was used for comparing two groups. P<0.05 was considered to indicate a statistically significant difference.
Results
Baicalein induces the apoptosis of HCT116, A549 and Panc-1 cells. Firstly, an MTT assay was performed to confirm that the appropriate concentration of baicalein was used. The data from the HCT116 (Fig. 1A) and FHC (Fig. 1B) cells demonstrated that 40 µM baicalein significantly inhibited the proliferation of HCT116 (~24%) and cased less damage to FHC cells (~10%). Subsequently, to detect the effect of baicalein on human cancer cells, light microscopy was used to observe the morphological changes of HCT116, A549 and Panc-1 cells following treatment with 0, 10, 20 or 40 µM baicalein with 1 µM gemcitabine serving as a positive control. As shown in Fig. 1C , cells treated with baicalein (10, 20 or 40 µM) or gemcitabine (1 µM) were in flattened, blebby and shrunken in appearance, consistent with cell death, whereas the negative control cells presented with an intact and polygonal morphology. Additionally, baicalein markedly inhibited the proliferation of HCT116 (Fig. 1D) , A549 (Fig. 1E) , and Panc-1 (Fig. 1F ) cells in a dose-dependent manner. For example, 40 µM baicalein inhibited proliferation by up to 90%. Furthermore, the data indicated that baicalein induced apoptosis of the HCT116 cells in a dose-dependent manner as assessed by the Annexin V/PI double staining assay ( Fig. 2A) , and significantly increase the levels of cleaved-caspase-3 and cleaved-caspase-9 (Fig. 2B) following treatment for the indicated times. Similar results were also observed in the A549 (Fig. 2C and D) and Panc-1 ( Fig. 2E and F) cells, suggesting that baicalein induced the apoptosis of HCT116, A549 and Panc-1 cells.
Expression levels of DEPP and Gadd45a are elevated in cancer cells subjected to baicalein-induced apoptosis. To verify the potential role of DEPP and Gadd45a in baicaleininduced apoptosis, the present study investigated whether the expression levels of DEPP and Gadd45a were altered in baicalein-treated cells. Western blot analysis (Fig. 3A) and RT-qPCR analysis (Fig. 3B) showed that the protein and mRNA expression levels of DEPP and Gadd45a were elevated more than two-fold in the baicalein-treated HCT116 cells. The data for protein levels in the A549 and Panc-1 cells were similar to those for the HCT116 cells. However, the mRNA expression of DEPP and Gadd45a in the A549 and Panc-1 cells had distinctly increased following 6 h of baicalein treatment, vs. 24 h of treatment (Fig. 3C-F) , which may be attributable to the delay between transcription and translation. These results confirmed that baicalein upregulated DEPP and Gadd45a in three distinct human cancer cell lines.
DEPP and Gadd45a deficiency inhibits baicalein-induced apoptosis of HCT116 cells.
To determine whether DEPP and Gadd45a were necessary for baicalein-induced apoptosis, siRNA against either DEPP or Gadd45a was transfected into HCT116 cells. Western blot analysis showed that the accumulation of baicalein-induced cleaved-caspase-3 and cleaved-caspase-9 were markedly reduced when DEPP and Gadd45a were silenced ( Fig. 4A and B) . These results were further confirmed by the Annexin V/PI double staining assay. As shown in Fig. 4C and D, there was a decrease of ~10% in the apoptotic rate of cells treated with 40 µM baicalein when transfected with either DEPP siRNA or Gadd45a siRNA, compared with cells transfected with non-specific siRNA. Taken together, these data showed that baicalein upregulated the expression of DEPP and Gadd45a, which was involved in the apoptotic response in HCT116 cells through the activation of caspase-3 and caspase-9. of MAPKs. To further elucidate the mechanism linking baicalein-induced apoptosis and the expression of DEPP and Gadd45a, the activation of MAPK was examined using an immunoblot assay in HCT116 cells at 0, 6, 12 and 24 h post-baicalein treatment. Notably, increases in the phosphorylation of JNK, ERK and p38 were observed in the western blot analysis (Fig. 5A) . The expression of DEPP was then stably inhibited using siRNA to determine whether DEPP is required for the baicalein-induced phosphorylation of MAPKs. Following baicalein treatment, the absence of DEPP (Fig. 5B and C) had a negative effect on the baicaleinmediated protein expression of p-JNK, p-ERK, p-p38 and Gadd45a, or on the mRNA expression of p21, p53 and Gadd45a. In addition, a DEPP-overexpression plasmid was used to further validate these findings (Fig. 5D) . Similarly, p-JNK, p-ERK, p-p38, p21, and p53 were induced only when the overexpression of DEPP was present ( Fig. 5D  and E) . Furthermore, the gene expression of Gadd45a was increased by 1.60-fold. Together, these results suggested that DEPP is required for the baicalein-induced phosphorylation of MAPKs and upregulated expression of Gadd45a at the protein and mRNA levels. The present study subsequently examined whether Gadd45a also regulated the baicaleininduced phosphorylation of MAPKs, and similar results were observed in the levels of p-JNK, p-ERK and p-p38 in cells transfected with siRNA against Gadd45a (Fig. 5F ). In summary, these data suggested that DEPP and Gadd45a are essential in baicalein-induced apoptosis via MAPK signaling.
Baicalein-induced HCT116 cell apoptosis via the upregulation of DEPP/Gadd45a is mediated by the phosphorylation

Baicalein-induced upregulation of Gadd45a is attenuated by inhibiting the phosphorylation of MAPK.
The abovementioned results showed that Gadd45a upregulated the phosphorylation of JNK, ERK and p38 in the baicalein-induced apoptosis of HCT116 cells. A previous report demonstrated that MAPK signaling mediates the expression of Gadd45a (14) . Therefore, to determine whether MAPK signaling was involved in the baicalein-mediated upregulation of Gadd45a, the JNK-specific inhibitor SP600125, p38 inhibitor SB203580, and ERK inhibitor SCH772084 were used to prevent the activation of JNK, p38 and ERK, respectively. The inhibition of JNK and p38 was accompanied by a marked decrease in the baicalein-induced expression of Gadd45a (Fig. 6A and B) , however, no such change was observed in the presence of the ERK inhibitor SCH772084 (Fig. 6C) . These results suggested that there was a positive feedback loop between Gadd45a and JNK/p38 when baicalein triggered the apoptotic response in human colon cancer cells, whereas the suppression of ERK had no effect on the expression of Gadd45a. Therefore, these data revealed the critical role of the activation of MAPK in inducting of the expression of Gadd45a in baicalein-induced apoptosis (Fig. 7) . 
Discussion
In the present study, it was shown that baicalein upregulated DEPP and Gadd45a, which activated caspase-3, caspaase-9 and the JNK/ERK/p38 MAPK pathways leading to apoptosis of HCT116 human colon cancer cells. As a natural compound extracted from Scutellaria baicalensis Georgi, baicalein has been widely investigated for its potent antitumor properties. The majority of studies have revealed that baicalein exerts its antitumor ability via the induction of apoptosis in human lung cancer (6), breast cancer (7) and osteosarcoma cells (16) . In addition, it also has been demonstrated that the MAPK signaling pathway results in the baicalein-induced apoptosis of cancer cells (7) . Therefore, the present study was performed to validate these findings and observed not only marked induction of apoptosis by baicalein in HCT116 colon cancer cells, A549 lung carcinoma cells and Panc-1 pancreatic cancer cells, but also the prominent activation of caspase-3, caspase-9 and JNK/ERK/p38 in baicalein-treated HCT116 cells.
However, whether the MAPKs functioned upstream or downstream to mediate baicalein-induced apoptosis remained to be elucidated. Therefore, on the basis of our previous results that DEPP and Gadd45a were markedly upregulated in baicalein-treated HCT116 cells by microarray, it was hypothesized DEPP and Gadd45a were important in baicaleininduced apoptosis and the activation of caspase-3, caspase-9 and MAPKs in HCT116 cells. Consistent with this hypothesis, the absence of DEPP notably decreased the apoptotic rate and the levels of pro-apoptotic proteins cleaved-caspase-3, cleaved-caspase-9, p-JNK/ERK/p38, p21, p53 and Gadd45a, all of which were induced by baicalein. Similar results were observed in HCT116 cells transfected with Gadd45a siRNA. Furthermore, the overexpression of DEPP provoked the phosphorylation of MAPKs and the expression of p21, p53 and Gadd45a. Taken together, these results indicated that as DEPP upregulated Gadd45a at the protein and mRNA levels, both these genes contribute to the activation of JNK/ERK/p38 during baicalein-induced apoptosis. However, further in vitro and in vivo investigations are required to examine whether baicalein has a direct impact on the expression of DEPP.
DEPP is a progesterone-induced gene that is regulated by progesterone in endometrial stromal cells and by insulin in adipose tissue. Additionally, it is induced in malignant glioma cells under hypoxic conditions (9, 10, 17) . However, there are few reports on its physiological function. Salcher et al found that the expression of DEPP contributes to Forkhead Box O3 (FOXO3)-induced apoptosis, as DEPP knockdown significantly reduced FOXO3-induced cell death (8) . Another study demonstrated that the upregulation of DEPP activated MAPK signaling pathways to stimulate the transcription factor ELK1 (17) . Therefore, the findings in the present study that DEPP promoted baicalein-induced apoptosis by the activation of Gadd45a, JNK/ERK/p38, caspase-3 and caspase-9, can drive further investigations regarding the physiological function of DEPP. However, there remain several questions in terms of how baicalein increases the mRNA and protein levels of DEPP and how DEPP induces the phosphorylation of MAPKs, two activities requiring thorough investigation.
In contrast to DEPP, the induction of Gadd45a and apoptosis via the MAPK signaling pathway has been examined extensively (13, 14) . However, detailed conclusions regarding the feedback loop between Gadd45a and MAPKs remain to be fully elucidated as reports have conflicting data. Certain reports have shown that Gadd45a is upstream of MAP signaling and activates the JNK pathway (18) , whereas others have suggested that Gadd45a is downstream of MAPK pathways, and is positively regulated by JNK and negatively regulated by ERK/p38 (14) . Accordingly, the analyses in the present study of the mediation between the expression of Gadd45a and baicalein-induced activation of JNK/ERK/ p38 in human colon cancer cells is useful as a supplement to previously published data. The in vitro experiments suggested the existence of a positive feedback loop between Gadd45a and JNK/p38. However, further investigations on the detailed role of Gadd45a and JNK/p38 on this loop, and the role of ERK outside this loop, in baicalein-induced apoptosis are required.
In conclusion, the present study provided evidence of a novel mechanism of baicalein-induced apoptosis in human colon cancer cells and found for the first time, to the best of our knowledge, that baicalein upregulated DEPP and Gadd45a, leading to apoptosis via the MAPK signaling pathway and the activation of caspase-3 and caspase-9 in HCT116 cells. In this context, the existence of a positive feedback loop between Gadd45a and JNK/p38 was also confirmed. In general, the findings of the present study may encourage the development of novel options to target DEPP and the Gadd45a-JNK/p38 feedback loop in the treatment of colon cancer.
